# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY

A. 510(k) Number: k072892   
B. Purpose for Submission: New devices: Triage $^ \mathrm { \textregistered }$ Total Controls 5 and Triage $^ \mathrm { \textregistered }$ Total Calibration Verificati   
C. Measurand: Control and calibrator verification material for test systems containing CK-MB, Myoglobin, Troponin I, $\beta .$ -type natriuretic peptide (BNP), and D-Dimer   
D. Type of Test: Control materials   
E. Applicant: Biosite Incorporated   
F. Proprietary and Established Names: Triage $^ \mathrm { \textregistered }$ Total Controls 5 Triage $^ \mathrm { \textregistered }$ Total Calibration Verification 5

# G. Regulatory Information:

1. Regulation section:   
21 CFR§862.1660

2. Classification: Class I, reserved

3. Product code: JJY

4. Panel: Clinical Chemistry (75)

# H. Intended Use:

1. Intended use(s): See indication for use

2. Indication(s) for use:

The Triage $^ \mathrm { \textregistered }$ Total Controls 5 are assayed materials to be used with the Triage $^ \mathrm { \textregistered }$ Profiler S.O.B.™ Panel, Triage $^ \mathrm { \textregistered }$ CardioProfilER $^ \mathrm { \textregistered }$ Panel, Triage Cardiac Panel, Triage $^ \mathrm { \textregistered }$ BNP Test, Triage $^ \mathrm { \textregistered }$ D-Dimer Test and the Triage Meters to assist in monitoring test performance.

The Triage $^ \mathrm { \textregistered }$ Total Calibration Verification 5 are assayed materials to be used with the Triage $^ \mathrm { \textregistered }$ Profiler S.O.B.™ Panel, Triage CardioProfilER $^ \mathrm { \textregistered }$ Panel, Triage $^ \mathrm { \textregistered }$ Cardiac Panel, Triage $^ \mathrm { \textregistered }$ BNP Test, Triage $^ \mathrm { \textregistered }$ D-Dimer Test and the Triage Meters to verify the calibration of the Test Devices throughout the measurable range.

3. Special conditions for use statement(s): Prescription Use

4. Special instrument requirements: Triage MeterPlus $^ \mathrm { \textregistered }$ and Triage MeterPro $^ \mathrm { \textregistered }$

# I. Device Description:

The Triage $^ \mathrm { \textregistered }$ Total Control 5 Controls 1 and 2, and the Triage $^ \mathrm { \textregistered }$ Total Calibration Verification 5 Levels A, B, C, D, E are single-use $0 . 2 9 \mathrm { m L }$ unit dose quality control materials prepared with concentrated purified CK-MB, myoglobin, troponin I, BNP and D-Dimer and human EDTA plasma at defined levels. The human plasma material has been tested for hepatitis B surface antigen, antibodies to hepatitis C, and antibodies against human immunodeficiency virus. The controls are stored frozen at $< - 2 0 ^ { \circ } \mathrm { C }$ . Preservatives and stabilizers are added to maintain product integrity.

# J. Substantial Equivalence Information:

1. Predicate device name(s): Triage $^ \mathrm { \textregistered }$ Profiler S.O.B. (Shortness of Breath) Controls

# Triage $^ \mathrm { \textregistered }$ Profiler S.O.B. Calibration Verification Controls

2. Predicate K number(s): k040459

3. Comparison with predicate:

<table><tr><td rowspan=1 colspan=3>Similarities-Triage® Total Controls 5</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Device</td><td rowspan=1 colspan=1>Predicate</td></tr><tr><td rowspan=1 colspan=1>Intended use</td><td rowspan=1 colspan=1>The Triage Total Controls are assayedmaterials to be used with the Triage ProfilerS.O.B. Panel, Triage CardioProfilER Panel,Triage Cardiac Panel, Triage BNP Test,Triage D-Dimer Test and the Triage Meters toassist in monitoring test performance.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Form</td><td rowspan=1 colspan=1>Liquid</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Analytes</td><td rowspan=1 colspan=1>CK-MB, myoglobin, Troponin I, BNP, D-Dimer</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Storage (unopened)</td><td rowspan=1 colspan=1>≤ -20°</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Matrix</td><td rowspan=1 colspan=1>EDTA Human Plasma</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Room Temp claim</td><td rowspan=1 colspan=1>30 minutes</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Levels</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>Same</td></tr></table>

<table><tr><td rowspan=1 colspan=3>Differences - Triage® Total Controls 5</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Device</td><td rowspan=1 colspan=1>Predicate</td></tr><tr><td rowspan=1 colspan=1>Packaging</td><td rowspan=1 colspan=1>0.29 mL polystyrene unit-dose vial 3.0 mL polypropylene vial</td><td rowspan=1 colspan=1>3.0 mL polypropylene vial</td></tr></table>

<table><tr><td colspan="3" rowspan="1">Similarities - Triage® Total Calibration Verification 5</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">Device</td><td colspan="1" rowspan="1">Predicate</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">The Triage Total Calibration Verification 5materials are to be used with the TriageProfiler S.O.B. Panel, Triage CardioProfilERPanel, Triage Cardiac Panel, Triage BNPTest, Triage D-Dimer Test and Triage Metersto verify the calibration of the Test Devicesthroughout the measurable range.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Form</td><td colspan="1" rowspan="1">Liquid</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Analytes</td><td colspan="1" rowspan="1">CK-MB, myoglobin, Troponin I, BNP, D-Dimer</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Storage (unopened)</td><td colspan="1" rowspan="1">≤-20°C</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Matrix</td><td colspan="1" rowspan="1">EDTA Human Plasma</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Room Temp claim</td><td colspan="1" rowspan="1">30 minutes</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Levels</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="3" rowspan="1">Differences - Triage® Total Calibration Verification 5</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">Device</td><td colspan="1" rowspan="1">Predicate</td></tr><tr><td colspan="1" rowspan="1">Packaging</td><td colspan="1" rowspan="1">0.29 mL polystyrene unit-dose vial 3.0 mL polypropylene vial</td><td colspan="1" rowspan="1">3.0 mL polypropylene vial</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

No standard/guidance documents were referenced.

L. Test Principle: Not applicable

# M. Performance Characteristics (if/when applicable):

1. Analytical performance: a. Precision/Reproducibility: Not applicable b. Linearity/assay reportable range: Not applicable c. Traceability, Stability, Expected values (controls, calibrators, or methods): Traceability

The materials are traceable to in-house purified, and analyzed antigens.

# Stability

Closed vial stability was performed at $\leq - 2 0 ^ { \circ } \mathrm { C }$ . The devices are single use products. Recovery at all time points tested was within sponsor’s acceptance criteria of $80 \mathrm { - } 1 2 0 \%$ .

# Expected values

Values assigned to the controls are obtained from multiple runs of Triage $^ \mathrm { \textregistered }$ Total Calibration Verification 5 and Triage $^ \mathrm { \textregistered }$ Total Controls 5 on multiple device lots over several days.

d. Detection limit:

Not applicable

e. Analytical specificity: Not applicable   
f. Assay cut-off: Not applicable

2. Comparison studies:

a. Method comparison with predicate device: Not applicable

b. Matrix comparison: Not applicable

3. Clinical studies:

a. Clinical Sensitivity: Not applicable

b. Clinical specificity: Not applicable   
c. Other clinical supportive data (when a. and b. are not applicable):

4. Clinical cut-off: Not applicable

5. Expected values/Reference range: Not applicable

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.